Glomerular Hyperfiltration and Renal Progression in Children with Autosomal Dominant Polycystic Kidney Disease

被引:62
|
作者
Helal, Imed [1 ]
Reed, Berenice [1 ]
McFann, Kim [1 ]
Yan, Xiang-Dong [1 ]
Fick-Brosnahan, Godela M. [1 ]
Cadnapaphornchai, Melissa [1 ]
Schrier, Robert W. [1 ]
机构
[1] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2011年 / 6卷 / 10期
关键词
VOLUME PROGRESSION; ADPKD; DIAGNOSIS; RISK; MICROALBUMINURIA; CREATININE; GROWTH; END;
D O I
10.2215/CJN.01010211
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The purpose of this study was to determine whether glomerular hyperfiltration (GH) occurring early in autosomal dominant polycystic kidney disease (ADPKD) is indicative of more rapid disease progression in children. Design, setting, participants, & measurements One hundred eighty children with ADPKD (ages 4 to 18 years) with normal renal function were examined by renal ultrasound. Renal volume was calculated using a standard formula for a modified ellipsoid. Creatinine clearance was calculated from serum creatinine and 24-hour urine creatinine. GH was defined as creatinine clearance >= 140 ml/min per 1.73 m(2). Results Thirty-two children had GH (mean age 11.4 +/- 3.6 years) and 148 had normal renal function (mean age 10.8 +/- 3.9 years). Patients with GH at baseline demonstrated an increased rate of total renal volume growth (beta: rate of change = +19.3 +/- 10.8 cm(3)/year) over 5 years compared with those without GH at baseline (beta = -4.3 +/- 7.7 cm(3)/year), P = 0.008. Those with GH at baseline experienced a faster decline in creatinine clearance in subsequent years (beta = 5.0 +/- 0.8 ml/min per 1.73 m(2) per year) compared with those without GH at baseline (beta = +1.0 +/- 0.4 ml/min per 1.73 m(2) per year), P < 0.0001. Conclusions This study revealed that occurrence of CH in ADPKD children is associated with a significantly faster decline in renal function and higher rate of kidney enlargement over time. GH combined with the increased renal volume may therefore be used as an early marker for a more severe progression of ADPKD in children. J Am Soc Nephrol 6: 2439-2443, 2011. doi: 10.2215/CJN.01010211
引用
收藏
页码:2439 / 2443
页数:5
相关论文
共 50 条
  • [41] Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
    Baur, Brian P.
    Meaney, Calvin J.
    PHARMACOTHERAPY, 2014, 34 (06): : 605 - 616
  • [42] Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease
    Han, Miyeun
    Park, Hayne Cho
    Kim, Hyunsuk
    Jo, Hyung Ah
    Huh, Hyuk
    Jang, Joon Young
    Kang, Ah-Young
    Kim, Seung Hyup
    Cheong, Hae Il
    Kang, Duk-Hee
    Yang, Jaeseok
    Oh, Kook-Hwan
    Hwang, Young-Hwan
    Ahn, Curie
    BMC NEPHROLOGY, 2014, 15
  • [43] Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease
    Jones, Brian E.
    Mkhaimer, Yaman G.
    Rangel, Laureano J.
    Chedid, Maroun
    Schulte, Phillip J.
    Mohamed, Alaa K.
    Neal, Reem M.
    Zubidat, Dalia
    Randhawa, Amarjyot K.
    Hanna, Christian
    Gregory, Adriana, V
    Kline, Timothy L.
    Zoghby, Ziad M.
    Senum, Sarah R.
    Harris, Peter C.
    Torres, Vicente E.
    Chebib, Fouad T.
    KIDNEY360, 2022, 3 (03): : 465 - 476
  • [44] Recent advances in management of autosomal-dominant polycystic kidney disease
    Potts, Jacob W.
    Mousa, Shaker A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (23) : 1959 - 1968
  • [45] Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease
    Chebib, Fouad T.
    Jung, Yeonsoon
    Heyer, Christina M.
    Irazabal, Maria V.
    Hogan, Marie C.
    Harris, Peter C.
    Torres, Vicente E.
    El-Zoghby, Ziad M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (06) : 952 - 960
  • [46] Feasibility of Water Therapy for Slowing Autosomal Dominant Polycystic Kidney Disease Progression
    Dev, Hreedi
    Zhu, Chenglin
    Barash, Irina
    Blumenfeld, Jon D.
    He, Xinzi
    Roychoudhury, Arindam
    Wu, Alan
    Prince, Martin R.
    KIDNEY360, 2024, 5 (05): : 698 - 706
  • [47] Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease
    Bae, Kyongtae T.
    Tao, Cheng
    Feldman, Robert
    Yu, Alan S. L.
    Torres, Vicente E.
    Perrone, Ronald D.
    Chapman, Arlene B.
    Brosnahan, Godela
    Steinman, Theodore I.
    Braun, William E.
    Mrug, Michal
    Bennett, William M.
    Harris, Peter C.
    Srivastava, Avantika
    Landsittel, Douglas P.
    Abebe, Kaleab Z.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (03): : 374 - 384
  • [48] Urine Fetuin-A is a biomarker of autosomal dominant polycystic kidney disease progression
    Nathalie Piazzon
    Florian Bernet
    Linda Guihard
    Wouter N Leonhard
    Séverine Urfer
    Dmitri Firsov
    Hassib Chehade
    Bruno Vogt
    Sophia Piergiovanni
    Dorien JM Peters
    Olivier Bonny
    Daniel B Constam
    Journal of Translational Medicine, 13
  • [49] Autosomal-dominant polycystic kidney disease in infancy and childhood: Progression and outcome
    Shamshirsaz, A
    Bekheirnia, RM
    Kamgar, M
    Johnson, AM
    McFann, K
    Cadnapaphornchai, M
    Haghighi, NN
    Schrier, RW
    KIDNEY INTERNATIONAL, 2005, 68 (05) : 2218 - 2224
  • [50] Optimal equation for estimation of glomerular filtration rate in autosomal dominant polycystic kidney disease: influence of tolvaptan
    Yamaguchi, Tsuyoshi
    Higashihara, Eiji
    Okegawa, Takatsugu
    Miyazaki, Isao
    Nutahara, Kikuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (05) : 1213 - 1223